Search research articles
Contact Us
Filters
Showing results (31-40 of 40) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 40 results.
Journal of the American Society of Nephrology : JASN
|
January 19, 2018
Uremic Solute-Aryl Hydrocarbon Receptor-Tissue Factor Axis Associates with Thrombosis after Vascular Injury in Humans
Vijaya B Kolachalama, Moshe Shashar, Faisal Alousi, et al.
Blood
|
December 27, 2019
Metabolites in a mouse cancer model enhance venous thrombogenicity through the aryl hydrocarbon receptor-tissue factor axis
Mostafa Belghasem, Daniel Roth, Sean Richards, et al.
Cell Reports. Medicine
|
June 4, 2026
HIV tri-specific killer engagers directly enhance NK cell function and safely expand NK cells in vivo
Ross T Cromarty, Julien A Clain, Yvette Soigner, et al.
Scientific Reports
|
December 29, 2019
c-Cbl targets PD-1 in immune cells for proteasomal degradation and modulates colorectal tumor growth
Chimera Lyle, Sean Richards, Kei Yasuda, et al.
The American Journal of Pathology
|
July 22, 2018
c-Cbl Expression Correlates with Human Colorectal Cancer Survival and Its Wnt/β-Catenin Suppressor Function Is Regulated by Tyr371 Phosphorylation
Sowmiya Kumaradevan, Shin Yin Lee, Sean Richards, et al.
The Journal of Infectious Diseases
|
February 17, 2017
Application of a Novel CD206+ Macrophage-Specific Arterial Imaging Strategy in HIV-Infected Individuals
Markella V Zanni, Mabel Toribio, Moses Q Wilks, et al.
Science Translational Medicine
|
November 24, 2017
Targeting STUB1-tissue factor axis normalizes hyperthrombotic uremic phenotype without increasing bleeding risk
Moshe Shashar, Mostafa E Belghasem, Shinobu Matsuura, et al.
Cancer Research
|
November 2, 2013
OX40 is a potent immune-stimulating target in late-stage cancer patients
Brendan D Curti, Magdalena Kovacsovics-Bankowski, Nicholas Morris, et al.
Nuclear Medicine and Biology
|
November 22, 2016
Corrigendum to the inextricable axis of targeted diagnostic imaging and therapy: An immunological natural history approach [Nucl Med Biol 43 (2016) 215-225]
Frederick O Cope, Bonnie Abbruzzese, James Sanders, et al.
Nuclear Medicine and Biology
|
March 1, 2016
The inextricable axis of targeted diagnostic imaging and therapy: An immunological natural history approach
Frederick O Cope, Bonnie Abbruzzese, James Sanders, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 40) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 40 results.
Journal of the American Society of Nephrology : JASN
|
January 19, 2018
Uremic Solute-Aryl Hydrocarbon Receptor-Tissue Factor Axis Associates with Thrombosis after Vascular Injury in Humans
Vijaya B Kolachalama, Moshe Shashar, Faisal Alousi, et al.
Blood
|
December 27, 2019
Metabolites in a mouse cancer model enhance venous thrombogenicity through the aryl hydrocarbon receptor-tissue factor axis
Mostafa Belghasem, Daniel Roth, Sean Richards, et al.
Cell Reports. Medicine
|
June 4, 2026
HIV tri-specific killer engagers directly enhance NK cell function and safely expand NK cells in vivo
Ross T Cromarty, Julien A Clain, Yvette Soigner, et al.
Scientific Reports
|
December 29, 2019
c-Cbl targets PD-1 in immune cells for proteasomal degradation and modulates colorectal tumor growth
Chimera Lyle, Sean Richards, Kei Yasuda, et al.
The American Journal of Pathology
|
July 22, 2018
c-Cbl Expression Correlates with Human Colorectal Cancer Survival and Its Wnt/β-Catenin Suppressor Function Is Regulated by Tyr371 Phosphorylation
Sowmiya Kumaradevan, Shin Yin Lee, Sean Richards, et al.
The Journal of Infectious Diseases
|
February 17, 2017
Application of a Novel CD206+ Macrophage-Specific Arterial Imaging Strategy in HIV-Infected Individuals
Markella V Zanni, Mabel Toribio, Moses Q Wilks, et al.
Science Translational Medicine
|
November 24, 2017
Targeting STUB1-tissue factor axis normalizes hyperthrombotic uremic phenotype without increasing bleeding risk
Moshe Shashar, Mostafa E Belghasem, Shinobu Matsuura, et al.
Cancer Research
|
November 2, 2013
OX40 is a potent immune-stimulating target in late-stage cancer patients
Brendan D Curti, Magdalena Kovacsovics-Bankowski, Nicholas Morris, et al.
Nuclear Medicine and Biology
|
November 22, 2016
Corrigendum to the inextricable axis of targeted diagnostic imaging and therapy: An immunological natural history approach [Nucl Med Biol 43 (2016) 215-225]
Frederick O Cope, Bonnie Abbruzzese, James Sanders, et al.
Nuclear Medicine and Biology
|
March 1, 2016
The inextricable axis of targeted diagnostic imaging and therapy: An immunological natural history approach
Frederick O Cope, Bonnie Abbruzzese, James Sanders, et al.
Page
of 4